| CD4+ count–guided interruption of antiretroviral treatment Strategies for Management of Antiretroviral Therapy (SMART) Study Group New England Journal of Medicine 355 (22), 2283-2296, 2006 | 2675 | 2006 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1162 | 2008 |
| Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson, P Cahn, JJ Eron, ... Jama 308 (4), 387-402, 2012 | 1152 | 2012 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron, JE Gallant, ... Jama 316 (2), 191-210, 2016 | 839 | 2016 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ... Jama 320 (4), 379-396, 2018 | 712 | 2018 |
| Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel HF Günthard, JA Aberg, JJ Eron, JF Hoy, A Telenti, CA Benson, ... Jama 312 (4), 410-425, 2014 | 664* | 2014 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 576 | 2008 |
| Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy JH Elliott, F Wightman, A Solomon, K Ghneim, J Ahlers, MJ Cameron, ... PLoS pathogens 10 (11), e1004473, 2014 | 553 | 2014 |
| Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study BR Bavinton, AN Pinto, N Phanuphak, B Grinsztejn, GP Prestage, ... The lancet HIV 5 (8), e438-e447, 2018 | 510 | 2018 |
| Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons SM Crowe, JB Carlin, KI Stewart, CR Lucas, JF Hoy JAIDS Journal of Acquired Immune Deficiency Syndromes 4 (8), 770-776, 1991 | 504 | 1991 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ... Jama 324 (16), 1651-1669, 2020 | 446 | 2020 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 438 | 2010 |
| Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial A Carr, C Workman, DE Smith, J Hoy, J Hudson, N Doong, A Martin, ... Jama 288 (2), 207-215, 2002 | 392 | 2002 |
| Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study A Martin, DE Smith, A Carr, C Ringland, J Amin, S Emery, J Hoy, ... Aids 18 (7), 1029-1036, 2004 | 371 | 2004 |
| Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection MW Traeger, VJ Cornelisse, J Asselin, B Price, NJ Roth, J Willcox, BK Tee, ... Jama 321 (14), 1380-1390, 2019 | 357 | 2019 |
| Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis ACAP Leenders, P Reiss, P Portegies, K Clezy, WCJ Hop, J Hoy, ... Aids 11 (12), 1463-1471, 1997 | 348 | 1997 |
| New spectrum of fungal infections in patients with cancer E Anaissie, GP Bodey, H Kantarjian, J Ro, SE Vartivarian, R Hopfer, J Hoy, ... Reviews of infectious diseases 11 (3), 369-378, 1989 | 343 | 1989 |
| Continuous antiretroviral therapy decreases bone mineral density B Grund, G Peng, CL Gibert, JF Hoy, RL Isaksson, JC Shlay, E Martinez, ... Aids 23 (12), 1519-1529, 2009 | 266 | 2009 |
| Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons EJ Wright, B Grund, K Robertson, BJ Brew, M Roediger, MP Bain, ... Neurology 75 (10), 864-873, 2010 | 239 | 2010 |
| Quadruple-Drug Therapy for Mycobacterium avium-intracellulare Bacteremia in AIDS Patients J Hoy, A Mijch, M Sandland, L Grayson, R Lucas, B Dwyer Journal of Infectious Diseases 161 (4), 801-805, 1990 | 237 | 1990 |
Andrew CarrSt Vincent's Hospital and University of New South Wales, SydneyVerified email at stvincents.com.au
